COMPACT and molecular structure in toxicity assessment: A prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the NCI/NTP

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 5, 1996, Pages 1011-1016

  Lewis, David F V ^a   Ioannides, C ^a   Parke, D V ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

COMPACT; Cytochromes P450; Toxicity prediction

Indexed keywords

ANTHRAQUINONE; CARCINOGEN; CHLOROPRENE; CINNAMALDEHYDE; EMODIN; FURFURYL ALCOHOL; GALLIUM ARSENIDE; METAL ION; MOLYBDENUM; NITROMETHANE; PHENOLPHTHALEIN; PROPANOL; SCOPOLAMINE; SODIUM NITRITE; UNCLASSIFIED DRUG; VANADIUM PENTOXIDE; XYLENE; XYLENESULFONIC ACID;

AMES TEST; ANIMAL EXPERIMENT; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; CHROMOSOME ANALYSIS; COMPUTER ANALYSIS; CONFERENCE PAPER; LIPID SOLUBILITY; METABOLISM; MICRONUCLEUS; MUTAGENICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; RODENT; SALMONELLA;

ANIMALIA; BACTERIA (MICROORGANISMS); RODENTIA; SALMONELLA;

EID: 0029831688     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s51011     Document Type: Conference Paper

References (22)

1. Parke DV. Activation mechanisms to chemical toxicity. Arch Toxicol 60:5-15 (1987).
2. Lewis DFV. Computer-assisted methods in the evaluation of chemical toxicity. Rev Comput Chem 3:173-222 (1992).
3. Ioannides C, Lewis DFV, Parke DV. The use of computers in the safety evaluation of drugs and other chemicals. Eur J Drug Metab Pharmacokin 3:225-233 (1994).
4. Lewis DFV, Ioannides C, Parke DV. A retrospective evaluation of COMPACT predictions of the outcome of rodent carcinogenicity testing from the NTP rodent bioassay results of 40 chemicals. Environ Health Perspect 103:178-184 (1995).
5. Smithing MO, Darvas F. Hazardexpert: an expert system for predicting chemical toxicity. In: Food Safety Assessment (Finley JW, Robinson SF, Armstrong DJ, eds). Washington: American Chemical Society 1992;191-200.
6. Hansch C. Structure-activity relationships of chemical mutagens and carcinogens in QSAR. In: Environmental Toxicology, IV (Hermens JLM, Oppenhuizen A, eds). Amsterdam:Elsevier, 1991;17-29.
7. Lewis DFV, Ioannides C, Parke DV. Molecular modelling of cytochrome P4501A1: a putative access channel explains activity differences between structurally related benzo[a] and benzo[e]pyrene, and between 2- and 4-acetylaminfluorene. Toxicol Lett 71:235-243 (1994).
8. Ioannides C, Cheung Y-L, Wilson JP, Lewis DFV, Gray TJB. Importance of cytochrome P450 induction in chemical carcinogenesis: the case for 2- and 4-acetylaminofluorene. Chem Res Toxicol 6:535-541 (1993).
9. Lewis DFV, Parke MG, King RJB. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino-acid sequence homology. J Steroid Biochem Mol Biol 25:55-65 (1995).
10. Lewis DFV, Lake BG. The interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (ppar): a molecular modelling and QSAR study. Xenobiotica 23:79-96 (1993).
11. Parke DV, Ioannides C. The cytochromes P448 - a unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochem Pharmacol 38:1313-1319 (1987).
12. Lewis DFV. Computer modelling of cytochromes P450 and their substrates: a rational approach to the prediction of carcinogenicity. Front Biotransform 7:90-136 (1992).
13. Ioannides C, Lewis DFV, Parke DV. Computer modelling in predicting carcinogenicity. Eur J Cancer Prev 2:275-282 (1993).
14. Parke DV. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ Health Perspect 102:852-853 (1994).
15. Ioannides C, Parke DV. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab Rev 25:485-501 (1993).
16. Parke DV, Ioannides C, Lewis DFV. The role of cytochromes P450 in the detoxication and activation of drugs and other chemicals. Can J Physiol Pharmacol 69:537-549 (1991).
17. Ekström G, Ingelman-Sundberg M. Rat liver microsonal NAPDH-supported oxidase activity and lipid peroxidation dependent on ethanol inducible cytochrome P450 (P450 II E1). Biochem Pharmacol 38:131-1319 (1989).
18. Halliwell B, Gutteridge JHC. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol 186: 1-85 (1990).
19. Lewis DFV, Ioannides C, Parke DV. Validation of a novel molecular orbital approach (COMPACT) to the safety evaluation of chemicals by comparison with Salmonella mutagenicity and rodent carcinogenicity data evaluated by the US NCI/NTP. Mutat Res 291:61-77 (1993).
20. Lewis DFV, Ioannides C, Parke DV. A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing. Environ Health Perspect 103:178-184 (1995).
21. Poet TS, Brendel K, Halpert JR. Inactivation of cytochrome P4502B protects against cocaine-mediated toxicity in rat liver slices. Toxicol Appl Pharmacol 126:26-32 (1994).
22. NIOSH. Registry of Toxic Effects of Chemical Substances (RTECS). Cincinnati, OH:National Institute of Occupational Safety and Health, 1993.